This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hochman, J. Articles by Pe’er, J. Search for Related Content PubMed PubMed Citation Articles by Hochman, J. Articles by Pe’er, J.

Entry Routes of Malignant Lymphoma into the Brain and Eyes in a Mouse Model¹

Department of Cell and Animal Biology, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel [J. H., N. A.]; Institute of Neuropathology, University of Bonn Medical Center, D-53127 Bonn, Germany [M. D-S., O. D. W.]; and Department of Ophthalmology, Hadassah University Hospital, Jerusalem 91120, Israel [J. P.]

We have recently developed a novel mouse model for studying the infiltration of malignant lymphoma to the eye and brain. After i.p. inoculation of variant S49 mouse lymphoma cells into young mice (optimum: day 7 postnatal), specific homing of these cells (named Rev-2-T-6) to the brain and eyes took place. This model offers an opportunity to study the routes of infiltration to these sites and spread thereof, as well as the molecular mechanisms that govern this metastasis. By applying a time course histopathological analysis, we demonstrate that infiltration of the brain and eyes can be visualized as early as days 9 and 14 after inoculation, respectively. The lymphoma cells enter the brain preferentially through the choroid plexus and cranial nerves. Infiltration of the rostral part occurs before the caudal part of the brain. Once within the brain, the cells spread within it as well as migrate along the optic nerve sheath into the eyes, where they continue to migrate along the choroid, ciliary body, iris, and into the anterior chamber of the eye. The orbit is also infiltrated by the lymphoma cells. However, this occurs independent of the brain-optic nerve-intraocular route.

This article has been cited by other articles:

				R. Meyuhas, E. Pikarsky, E. Tavor, A. Klar, R. Abramovitch, J. Hochman, T. G. Lago, and A. Honigman A Key Role for Cyclic AMP-Responsive Element Binding Protein in Hypoxia-Mediated Activation of the Angiogenesis Factor CCN1 (CYR61) in Tumor Cells Mol. Cancer Res., September 1, 2008; 6(9): 1397 - 1409. [Abstract] [Full Text] [PDF]

				C.-C. Chan, M. Fischette, D. Shen, S. P. Mahesh, R. B. Nussenblatt, and J. Hochman Murine Model of Primary Intraocular Lymphoma Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 415 - 419. [Abstract] [Full Text] [PDF]

				C. Lugassy, H. K. Kleinman, J. A. Engbring, D. R. Welch, J. F. Harms, R. Rufner, G. Ghanem, S. R. Patierno, and R. L. Barnhill Pericyte-Like Location of GFP-Tagged Melanoma Cells: Ex Vivo and In Vivo Studies of Extravascular Migratory Metastasis Am. J. Pathol., April 1, 2004; 164(4): 1191 - 1198. [Abstract] [Full Text] [PDF]

				A. J.M. Ferreri, L. E. Abrey, J.-Y. Blay, B. Borisch, J. Hochman, E. A. Neuwelt, J. Yahalom, E. Zucca, F. Cavalli, J. Armitage, et al. Summary Statement on Primary Central Nervous System Lymphomas From the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002 J. Clin. Oncol., June 15, 2003; 21(12): 2407 - 2414. [Abstract] [Full Text] [PDF]